Tag Archives: Suraj Kalia

BioLife Solutions (BLFS) Received its Third Buy in a Row

After Maxim Group and H.C. Wainwright gave BioLife Solutions (NASDAQ: BLFS) a Buy rating last month, the company received another Buy, this time from Northland Securities. Analyst Suraj Kalia maintained a Buy rating on BioLife Solutions today and set a

Northland Securities Sticks to Its Hold Rating for Medtronic (MDT)

In a report released today, Suraj Kalia from Northland Securities maintained a Hold rating on Medtronic (MDT – Research Report), with a price target of $100. The company’s shares closed last Monday at $106.91, close to its 52-week high of

Northland Securities Sticks to Their Buy Rating for Viewray (VRAY)

In a report released today, Suraj Kalia from Northland Securities maintained a Buy rating on Viewray (VRAY – Research Report), with a price target of $5. The company’s shares closed last Monday at $4.50. Kalia commented: “We remain confident in

Northland Securities Sticks to Its Buy Rating for Varex Imaging Corporation (VREX)

Northland Securities analyst Suraj Kalia maintained a Buy rating on Varex Imaging Corporation (VREX – Research Report) today and set a price target of $42. The company’s shares closed yesterday at $30.93. According to TipRanks.com, Kalia is a 5-star analyst

Northland Securities Keeps a Hold Rating on Obalon Therapeutics Inc (OBLN)

Northland Securities analyst Suraj Kalia maintained a Hold rating on Obalon Therapeutics Inc (OBLN – Research Report) today and set a price target of $0.50. The company’s shares opened today at $0.66, close to its 52-week low of $0.37. Kalia

Northland Securities Keeps a Sell Rating on Intuitive Surgical (ISRG)

In a report issued on July 22, Suraj Kalia from Northland Securities maintained a Sell rating on Intuitive Surgical (ISRG – Research Report). The company’s shares closed yesterday at $537.79. According to TipRanks.com, Kalia is a 5-star analyst with an